Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HONG YUAN HOLDING GROUP (CERP)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
74.6
|
M
| |
|
|
| Market cap: |
$115.7
|
k
| |
|
|
|
Net cash:
|
|
| |
|
|
|
EV:
|
$115.7
|
k
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($58.3)
|
k
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 0.1 | 0.0 | 0.0 | 0.9 | 20.3 | 6.3 | 2.7 | 4.5 |
| Revenue growth | 26.1% | 3555.3% | | -95.6% | 219.3% | 131.6% | -39.3% | -99.8% |
| Cost of goods sold | 0.1 | 0.0 | 0.0 | 1.0 | 18.2 | 5.2 | 2.4 | 4.4 |
| Gross profit | 0.0 | 0.0 | 0.0 | -0.1 | 2.0 | 1.1 | 0.3 | 0.1 |
| Gross margin | 0.0% | 0.0% | -1393.6% | -9.1% | 10.0% | 17.3% | 12.3% | 1.8% |
| Selling, general and administrative | | | | 18.9 | 13.4 | 7.5 | | |
| Sales and marketing | | | | | | | 0.4 | 1.5 |
| Research and development | | | | 0.5 | 1.0 | 0.5 | 0.3 | 1.1 |
| General and administrative | 0.1 | 0.0 | 0.0 | | | | 0.7 | 1.0 |
| EBIT | -0.1 | 0.0 | 0.0 | -19.4 | -12.4 | -6.3 | -7.0 | -13.1 |
| EBIT margin | -100.0% | -100.0% | -1493.6% | -2173.3% | -61.3% | -99.3% | -256.3% | -289.7% |
| Pre-tax income | -0.1 | 0.0 | 0.0 | -30.2 | -14.0 | -7.5 | -6.1 | -12.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -0.1 | 0.0 | 0.0 | -30.2 | -14.0 | -7.5 | -6.1 | -12.7 |
| Net margin | -100.0% | -100.0% | -1393.5% | -3373.8% | -69.1% | -118.0% | -221.7% | -282.5% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | ($1.16) | ($0.88) | ($0.64) | ($0.75) | ($1.92) |
| Shares outstanding (diluted) | 74.6 | 74.6 | 74.6 | 26.0 | 16.0 | 11.8 | 8.0 | 6.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|